Seoul National University Hospital
Seoul, 110-744, South Korea
NCT Number: NCT01974492
In coronary artery bypass grafting, saphenous veins are widely used as a composite grafts that are Y-anastomosed to in-situ left internal thoracic artery. Based on our observation that remodeling of saphenous vein graft differs between those harvested from upper leg vein and lower leg, this study aims to compare histologic and immunohistochemical findings between saphenous vein grafts harvested from upper leg and lower leg.
Looking for future studies?
Notify Me40 year–75 year
All sexes
Interventional
Not applicable
Seoul, 110-744, South Korea
Inclusion criteria
Patients will be randomly assigned to upper leg vein (ULV) group and lower leg vein (LLV) group immediately after anesthetic induction.
Pieces of residual saphenous vein graft will be sent for histologic and immunohistochemical examination for the evaluation of endothelial cell preservation and the expression of matrix proteins.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients whose saphenous veins are harvested from upper legs.
Patients whose saphenous veins are harvested from lower legs.
Time frame: 1 year
Participants will be followed for the duration of hospital stay, an expected average of 1 week.
Seoul National University Hospital
Other
A Comparison of Histologic and Immunohistochemical Characteristics Between the Upper and Lower Leg Saphenous Veins Used for Coronary Artery Bypass Grafting
Acronym: COSAVEGUL-1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03103620
ACS - Acute Coronary Syndrome, Acute Coronary Syndrome
Aix, France
View Trial DetailsNCT01637012
Angina Pectoris, Angina, Stable
Krakow, Bochenka 12, Poland
View Trial DetailsNCT02176174
Abdominal Aortic Aneurysm, Aneurysm
View Trial DetailsNCT06404515
ASCVD, Acute Coronary Syndrome
New York, United States
View Trial Details